Vascular Stents Market: Trends, Growth, and Future Outlook (2025-2034)

The vascular stents market plays a pivotal role in the treatment of cardiovascular diseases, including coronary artery disease and peripheral artery disease. Stents are small, expandable tubes inserted into blood vessels to maintain blood flow and prevent blockages. As the global prevalence of cardiovascular diseases continues to rise, the demand for vascular stents is expected to increase significantly. In 2024, the vascular stents market reached a value of almost USD 10.57 billion, and it is projected to grow at a compound annual growth rate (CAGR) of 5.50% between 2025 and 2034, reaching a value of nearly USD 18.06 billion by 2034. This article delves into the key drivers, trends, market segmentation, and major players influencing the vascular stents market.

Market Overview

Vascular stents market  are widely used in interventional cardiology and vascular surgery to treat arterial blockages. The primary types of vascular stents include coronary stents, peripheral vascular stents, and endovascular stent grafts (EVAR). These devices are used to open narrowed or blocked arteries, preventing further complications such as heart attacks or strokes. The growing prevalence of chronic conditions like atherosclerosis, diabetes, and hypertension is increasing the need for vascular interventions. Additionally, advancements in stent technology, such as drug-eluting stents (DES), are boosting market growth. With ongoing innovations in stent materials and delivery systems, the vascular stents market is expected to expand significantly over the coming years.

Market Size and Share

The vascular stents market was valued at almost USD 10.57 billion in 2024, with significant growth expected in the coming decade. The market is forecast to expand at a CAGR of 5.50% during the period from 2025 to 2034, with the value likely to reach approximately USD 18.06 billion by 2034. Factors such as the increasing incidence of cardiovascular diseases, technological advancements in stent designs, and the growing number of surgeries requiring stent implants are all contributing to this market expansion. The rising adoption of minimally invasive procedures and a focus on improving patient outcomes are also pivotal in driving market growth.

Get a free sample request: https://www.expertmarketresearch.com/reports/vascular-stents-market/requestsample

Market Trends

• Rising Adoption of Drug-Eluting Stents
  Drug-eluting stents (DES) are gaining increasing popularity in the vascular stents market due to their ability to release medication that helps prevent artery re-narrowing. These stents are widely used in coronary artery disease (CAD) procedures to improve long-term outcomes and reduce the need for repeat interventions. The growing acceptance of DES is a key trend, driven by their improved performance compared to bare-metal stents, particularly in high-risk patients.
• Technological Advancements in Stent Materials
  Advancements in stent materials, such as bioabsorbable and biodegradable stents, are reshaping the vascular stents market. Bioabsorbable stents are designed to degrade over time, reducing the risk of long-term complications such as thrombosis. These innovations in materials not only improve the efficacy of vascular stents but also enhance patient safety and comfort. Ongoing research into new materials and coatings promises further enhancements in stent performance.
• Shift Toward Minimally Invasive Procedures
  There is a growing shift toward minimally invasive procedures in the healthcare sector, particularly in the cardiovascular field. Stent placement procedures, such as percutaneous coronary interventions (PCI), are being increasingly performed using catheter-based techniques rather than open surgeries. This trend is improving patient recovery times, reducing hospital stays, and lowering the overall cost of treatment. The rise of minimally invasive interventions is expected to continue supporting the growth of the vascular stents market.
• Growing Demand in Emerging Markets
  The demand for vascular stents is increasing in emerging markets due to improving healthcare infrastructure, rising disposable incomes, and increasing awareness of cardiovascular diseases. Countries in the Asia Pacific, Latin America, and the Middle East are witnessing a growing need for cardiovascular treatments, driven by an aging population and increasing rates of lifestyle diseases such as obesity and diabetes. This trend presents significant opportunities for market players to expand their presence in these regions.

Market Analysis

• Type Segmentation
  The vascular stents market is categorized into three main types: drug-eluting stents (DES), bare-metal stents (BMS), and bioabsorbable stents. DES, which release drugs to prevent re-narrowing of arteries, dominate the market due to their superior efficacy. Bare-metal stents, while still in use, are gradually being replaced by DES due to their higher risk of restenosis. Bioabsorbable stents, which dissolve over time, are a relatively newer addition to the market and offer promising advantages in reducing long-term complications.
• Product Type Segmentation
  The vascular stents market is further divided into coronary stents, peripheral vascular stents, and EVAR stent grafts. Coronary stents account for the largest share, driven by the high prevalence of coronary artery disease (CAD). Peripheral vascular stents are used to treat blockages in peripheral arteries, such as those in the legs, and are experiencing steady growth. EVAR stent grafts are used to treat aortic aneurysms, with a growing number of procedures being performed globally.
• Material Segmentation
  The two main materials used for stents are metallic stents and others, such as bioabsorbable stents. Metallic stents, made from materials like stainless steel, cobalt-chromium, and titanium, are widely used due to their strength and durability. Bioabsorbable stents, which are made from polymers or magnesium alloys, are gaining traction due to their ability to dissolve in the body after serving their purpose, reducing long-term complications like thrombosis and restenosis.
• Mode of Delivery Segmentation
  Vascular stents are delivered using two primary modes: balloon-expandable stents and self-expanding stents. Balloon-expandable stents are typically used in coronary artery procedures, where they are expanded using a balloon catheter to fit the artery. Self-expanding stents are used for peripheral artery interventions, where they expand on their own once placed. Both methods offer distinct advantages depending on the location and nature of the artery blockage.

Regional Insights

• North America
  North America dominates the vascular stents market, primarily due to the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and high healthcare spending. The United States, in particular, accounts for a significant portion of the market share, with a large number of stent procedures performed annually. The increasing adoption of drug-eluting stents and bioabsorbable stents further boosts the market in this region. Additionally, the presence of leading market players and a favorable regulatory environment contribute to the region's dominance.
• Europe
  Europe holds a significant share of the vascular stents market, driven by the rising aging population, the increasing burden of cardiovascular diseases, and advanced healthcare systems in countries like Germany, the United Kingdom, and France. The demand for drug-eluting stents and peripheral vascular stents is particularly high, as they are widely used to treat coronary artery disease and peripheral artery disease. The region is also seeing growing adoption of bioabsorbable stents, which is likely to drive future market growth.
• Asia Pacific
  The Asia Pacific region is expected to experience the highest growth rate in the vascular stents market due to the rapid improvement in healthcare infrastructure and rising rates of cardiovascular diseases. Countries like China, India, and Japan are seeing a surge in demand for vascular interventions, particularly in urban areas. The growing awareness of cardiovascular health, the availability of cost-effective treatment options, and government initiatives to improve healthcare access are all contributing to the region's market growth.
• Latin America and Middle East & Africa
  The vascular stents market in Latin America and the Middle East & Africa is witnessing gradual growth, driven by improvements in healthcare systems and increased awareness of heart health. While affordability remains a challenge in some regions, the market is expected to grow steadily as the prevalence of cardiovascular diseases rises and healthcare access improves. Countries like Brazil, Mexico, and Saudi Arabia are emerging as key markets for vascular stents in these regions.

Market Growth

Several factors are driving the growth of the vascular stents market. The increasing prevalence of cardiovascular diseases, especially coronary artery disease and peripheral artery disease, is a significant contributor. Advancements in stent technology, including drug-eluting stents and bioabsorbable stents, are improving patient outcomes and reducing the risk of restenosis and thrombosis. Furthermore, the shift toward minimally invasive procedures, which offer faster recovery times and lower risks, is also driving market demand. The growing adoption of stents in emerging markets, coupled with improvements in healthcare infrastructure, presents significant opportunities for market expansion.

Recent Developments & Challenges

• Innovations in Stent Technology
  Innovative stent technologies, such as bioabsorbable and biodegradable stents, are transforming the vascular stents market. These advancements promise to reduce complications and improve long-term patient outcomes by gradually dissolving in the body after serving their purpose.
• Regulatory Approvals
  New stent technologies are undergoing regulatory scrutiny and approval in key markets such as the United States and Europe. The rigorous regulatory processes are delaying the market entry of some products, but successful approvals are expected to spur market growth once these stents become available.
• Challenges in Affordability
  While the vascular stents market is growing, the high cost of advanced stent technologies, particularly drug-eluting and bioabsorbable stents, poses a challenge in some regions, especially in developing countries. Efforts to make stents more affordable and accessible to a broader patient population will be critical to sustaining market growth.
• Competition Among Market Players
  The vascular stents market is highly competitive, with numerous established companies vy

ing for market share. Leading players are focusing on product innovation, strategic partnerships, and geographic expansion to strengthen their positions in the market.

Key Players

• Abbott Laboratories
  Abbott Laboratories is a key player in the vascular stents market, known for its innovative drug-eluting stents and coronary artery disease solutions. The company has a strong presence in North America and Europe, with a wide range of products catering to various vascular conditions. Abbott continues to invest in research and development to expand its stent portfolio and enhance patient outcomes.
• Boston Scientific Corporation
  Boston Scientific is a leading manufacturer of vascular stents, offering products such as drug-eluting stents and peripheral artery stents. The company is known for its commitment to advancing minimally invasive techniques and improving patient care. Boston Scientific’s extensive global presence and focus on technological innovation make it a major player in the vascular stents market.
• Medtronic
  Medtronic is a global leader in medical devices, including vascular stents. The company offers a range of products, including coronary stents and peripheral vascular stents, aimed at improving blood flow and reducing complications in patients with cardiovascular diseases. Medtronic’s strong R&D capabilities and broad distribution network contribute to its leadership in the market.
• Biotronik, Inc.
  Biotronik is a prominent player in the vascular stents market, known for its cutting-edge drug-eluting stents and vascular intervention products. The company’s commitment to innovation, combined with a focus on improving patient outcomes, has helped it secure a strong position in the global market. Biotronik continues to expand its product offerings and market presence through strategic partnerships.

FAQs

. What is the difference between drug-eluting stents and bare-metal stents?
Drug-eluting stents release medication to prevent re-narrowing of arteries, while bare-metal stents are simply metal tubes without any drug coating.

. How long do vascular stents last?
Vascular stents are designed to last for many years, but their longevity depends on factors such as the type of stent used and the patient’s health condition. Drug-eluting stents are often used for long-term durability.

. Are vascular stent procedures safe?
Vascular stent procedures are generally safe, though risks such as infection, clotting, and restenosis can occur. These risks are minimized with proper patient selection and post-procedure care.

. Can stents be used for peripheral artery disease?
Yes, vascular stents are commonly used to treat peripheral artery disease by opening blocked or narrowed arteries in the legs and other peripheral regions.

More Related report: https://www.expertmarketresearch.com/healthcare-articles/top-vessel-sealing-devices-companies